uspc ifrb


Logo UP13



Valeyre D, Bernaudin JF, Jeny F, Duchemann B, Freynet O, Planès C, Kambouchner M, Nunes H. Pulmonary Sarcoidosis. Clin Chest Med. 2015;36(4):631-41. [IF=2.36]

Saidenberg-Kermanac'h N, Valeyre D, Boissier MC. Vitamin D Supplementation in Patients Treated for Sarcoidosis: Controversy or Consensus? Joint Bone Spine. 2017 Mar 17. pii: S1297-319X(17)30042-8. doi: 10.1016/j.jbspin.2017.03.003. [IF=3.33]

Valeyre D, Nathan N, Bernaudin JF. Inborn Errors of Metabolism: The Achilles' Heel of the Respiratory System. Respiration. 2017 May 24;94(1): 14-15. doi: 10.1159/000477430. [Epub ahead of print]. [IF=2.77]

Valeyre D, Jeny F, Nunes H. Current medical therapy for sarcoidosis. Semin Respir Crit Care Med 2017; 38: 1-9. [IF=2.27]

Martinod E, Paquet J, Dutau H, Radu DM, Bensidhoum M, Abad S, Uzunhan Y, Vicaut E, Petite H. In Vivo Tissue Engineering of Human Airways. Ann Thorac Surg. 2017 May;103(5):1631-1640. doi: 10.1016/j.athoracsur.2016.11.027. Epub 2017 Jan 18. [IF=3.7]


Culver DA, Valeyre D. Emerging ideas about sarcoidosis pathophysiology. Curr Opin Pulm Med. 2016;22(5):466-8. [IF=3.08]

Grenier PA, Fetita CI, Brillet PY. Quantitative computed tomography imaging of airway remodeling in severe asthma. Quant Imaging Med Surg. 2016;6(1):76-83.

Jeny F, Pacheco Y, Besnard V, Valeyre D, Bernaudin JF. Experimental models of sarcoidosis. Curr Opin Pulm Med. 2016;22(5):492-9. [IF=3.08]

Jeny F, Bouvry D, Freynet O, Soussan M, Brauner M, Planès C, Nunes H, Valeyre D. Management of sarcoidosis in clinical practice. Eur Respir Rev. 2016;25(140):141-50.

Richalet JP. Physiological and Clinical Implications of Adrenergic Pathways at High Altitude. Adv Exp Med Biol. 2016;903:343-56. [IF=1.88]


Jamilloux Y, Valeyre D, Lortholary O, Bernard C, Kerever S, Lelievre L, Neel A, Broussolle C, Seve P. The spectrum of opportunistic diseases complicating sarcoidosis. Autoimmun Rev. 2015;14(1):64-74. Review. [IF=8.96]

Nathan N, Marcelo P, Houdouin V, Epaud R, de Blic J, Valeyre D, Houzel A, Busson PF, Corvol H, Deschildre A, Clement A; RespiRare and the French Sarcoidosis groups. Lung sarcoidosis in children: update on disease expression and management. Thorax. 2015;70(6):537-42. [IF=8.27]

Richalet JP. Pro: Corticosteroids Are Useful in the Management of HAPE. High Alt Med Biol. 2015;16(3):186-9. [IF=1.71]

Richalet JP. Rebuttal to the Con Statement. High Alt Med Biol. 2015;16(3):193. [IF=1.71]

Silva M, Nunes H, Valeyre D, Sverzellati N. Imaging of Sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):45-53.


Cottin V, Cadranel J, Crestani B, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Valeyre D, Wallaert B, Bouquillon B, Cordier JF. Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists. Respir Med. 2014 Jan;108(1):195-202. [IF=3.04]

Soussan M, Abisror N, Abad S, Nunes H, Terrier B, Pop G, Eder V, Valeyre D, Sberro-Soussan R, Guillevin L, Dhote R, Fain O, Mekinian A. FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev. 2014 Feb;13(2):125-31. Review. [IF=8.96]

Richalet JP, Canoui-Poitrine F. Pro: hypoxic cardiopulmonary exercise testing identifies subjects at risk for severe high altitude illnesses. High Alt Med Biol. 2014;15(3):315-7. [IF=1.71]

Richalet JP, Canoui-Poitrine F. Rebuttal to the con statement. High Alt Med Biol. 2014;15(3):321. [IF=1.71]

Soussan M, Augier A, Brillet PY, Weinmann P, Valeyre D. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features. Clin Nucl Med. 2014 Feb;39(2):e146-59. [IF=3.64]

Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis. Lancet. 2014 Mar 29;383(9923):1155-67. Review. [IF=47.83]

Valeyre D, Nunes H, Bernaudin JF. Advanced pulmonary sarcoidosis. Curr Opin Pulm Med. 2014;20(5):488-95. Review. [IF=3.08]

Valeyre D, Bernaudin JF, Uzunhan Y, Kambouchner M, Brillet PY, Soussan M, Nunes H. Clinical presentation of sarcoidosis and diagnostic work-up. Semin Respir Crit Care Med. 2014 Jun;35(3):336-51. [IF=2.27]


Annesi-Maesano I, Nunes H, Duchemann B, Valeyre D, Agabiti N, Saltini C, Porretta MA. Epidemiology of idiopathic pulmonary fibrosis in Europe-an update. Sarcoidosis Vasc Diffuse Lung Dis. 2013 Sep 1;30 Suppl 1:6-12. [IF=1.58]

Jamilloux Y, Bonnefoy M, Valeyre D, Varron L, Broussolle C, Sève P. Elderly-onset sarcoidosis: prevalence, clinical course, and treatment. Drugs Aging. 2013 Dec;30(12):969-78. Review.

Burgel PR, Bergeron A, de Blic J, Bonniaud P, Bourdin A, Chanez P, Chinet T, Dalphin JC, Devillier P, Deschildre A, Didier A, Kambouchner M, Knoop C, Laurent F, Nunes H, Perez T, Roche N, Tillie-Leblond I, Dusser D. Small airways diseases, excluding asthma and COPD: an overview. Eur Respir Rev. 2013; 1;22(128):131-47.

Baughman RP, Nunes H, Sweiss NJ, Lower EE. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J. 2013 Jun;41(6):1424-38. Review. [IF=10.57]

Baughman RP, Nunes H. Sarcoidosis-associated fatigue: an often forgotten symptom--author reply. Expert Rev Clin Immunol. 2013 Feb;9(2):111. [IF=3.27]

Israel-Biet D, Valeyre D. Diagnosis of pulmonary sarcoidosis. Curr Opin Pulm Med. 2013 Sep;19(5):510-5. Review. [IF=3.08]

West JB, Richalet JP. Denis Jourdanet (1815-1892) and the early recognition of the role of hypoxia at high altitude. Am J Physiol Lung Cell Mol Physiol. 2013;305(5):L333-40. [IF=4.28]


Baughman RP, Nunes H. Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol 2012;8:95-103. [IF=3.27]

Mekinian A, Jaccard A, Soussan M, Launay D, Berthier S, Federici L, Lefèvre G, Valeyre D, Dhote R, Fain O; Centre de Référence des Amyloses immunoglobulinémiques et autres maladies liées aux dépots des immunoglobulines monoclonales. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid. 2012 Jun;19(2):94-8. [IF=3.37]

visuel hypoxie smbh2